
THE VALUE OF OSTEOPONTIN AS A DIAGNOSTIC BIOMARKER IN POSTMENOPAUSAL OSTEOPOROSIS; A REVIEW.
Author(s) -
Amira A. Atta,
AUTHOR_ID
Publication year - 2020
Publication title -
journal of applied pharmacy
Language(s) - English
Resource type - Journals
ISSN - 1920-4159
DOI - 10.21065/19204159.12.27
Subject(s) - osteoporosis , osteopontin , bone mineral , medicine , biomarker , dual energy x ray absorptiometry , dual energy , omics , osteoporotic fracture , postmenopausal women , bioinformatics , radiology , biology , biochemistry
Although increased awareness of morbidity and costs related to osteoporotic fractures, real progress achieved only through early detection of osteoporosis before any fractures occur. Dual Energy X-ray Absorptiometry (DEXA) is commonly used for diagnosis of osteoporosis by measuring bone mineral density (BMD